Cytovale Inc.
Medical device company · San Francisco, California, United States
Cytovale Inc. is a medical device company headquartered in San Francisco, California, United States. The US FDA lists 1 medical device site registered to the company, with devices in microbiology. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $2.8 million in total, most recently in 2016. It has reported private securities offerings to the US SEC, most recently $16 million sold in a notice filed in 2022.
Cytovale at a glance
What does Cytovale do?
Medical specialties of its FDA-listed devices
Device types listed with the FDA
US government research funding
4 SBIR/STTR small-business research awards from US health agencies, $2.8 million in total (2013 to 2016). NIH funding came from the National Heart, Lung, and Blood Institute.
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $16.4 million sold (2022).
Where is Cytovale located?
Headquarters: San Francisco, California, United States
- South San Francisco, CaliforniaCytovale, Inc. · FDA device site
Frequently asked questions about Cytovale
Where is Cytovale headquartered?
Cytovale Inc. is headquartered in San Francisco, California, United States.
What does Cytovale do?
Cytovale Inc. is a medical device company. Its FDA-listed medical devices fall under microbiology.
Similar companies
- Heartflow, Inc.San Francisco, California, United States
- iRhythm Holdings, Inc.San Francisco, California, United States
- Posit Science CorpSan Francisco, California, United States
- Adynxx, Inc.San Francisco, California, United States
- Claria Medical, Inc.San Francisco, California, United States
- Neuro42, Inc.San Francisco, California, United States
- ReThink Medical, Inc.San Francisco, California, United States
- Teal Health IncSan Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences